Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  SYRINGES (DISPOSABLE AND REUSABLE)
A Global Strategic Business Report

This report analyzes the worldwide markets for Syringes (Reusable and Disposable) in Millions of US$. The specific product segments analyzed are Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 149 companies including many key and niche players worldwide such as Becton, Dickinson and Company, BMDI TUTA Limited, C. R. Bard, Inc., Ensi-Med International Pty Limited, Kawamoto Corporation, Medline Industries Inc., Merit Medical Systems, Inc., Safety Syringes, Inc., Smiths Medical International Ltd., Terumo Corporation, and Terumo Medical Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3229  PAGES:    440
PRICE:    $3450  DATE:       October 2008
COMPANIES:  149  MARKET DATA TABLES:   139
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  SYRINGES (DISPOSABLE AND REUSABLE) (Complete Report) Pages : 440   | $3450
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS5$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Definition of Product Segments.....I-3
Anesthesia Syringes.....I-3
  
   Angiographic Syringes.....I-4
Blood Gas Syringes.....I-4
Catheter Syringes.....I-4
Dental Syringes.....I-4
Ear Syringes.....I-4
Hypodermic Syringes.....I-4
  
   Insulin Syringes.....I-5
Intraligamentary Syringes.....I-5
Irrigating Syringes.....I-5
  
II. EXECUTIVE SUMMARY67$1950
  1. Global Market Analysis And Overview.....II-12 $200  
   Industry Snapshots.....II-1
Factors Driving Growth.....II-1
2$200
  2. Market Dynamics.....II-34 $400  
   Safety Syringes.....II-3
Needleless Systems Pose a Threat to Traditional Syringes.....II-3
Facts About Needlesticks.....II-3
1$100
   Prefilled Syringes - Another Key Trend.....II-4
Changes in Syringe Materials.....II-4
Pricing Trends.....II-4
1$100
   Diabetics - Major End-Users of Syringes.....II-5
Alternative to Syringes.....II-5
Insulin Infusion Pumps.....II-5
Preloaded Insulin Pens.....II-5
Pulmonary Drug Delivery.....II-5
2$200
  3. Product Overview.....II-73 $300  
   Syringes.....II-7
Disposable Syringe.....II-7
Reusable Syringe.....II-7
Product Segments.....II-7
Anesthesia Syringes.....II-7
Angiographic Syringes.....II-7
Blood Gas Syringes.....II-7
1$100
   Catheter Syringes.....II-8
Dental Syringes.....II-8
Ear Syringes.....II-8
Hypodermic Syringes.....II-8
Insulin Syringes.....II-8
1$100
   Intraligamentary Syringes.....II-9
Irrigating Syringes.....II-9
1$100
  4. Pre-Filled Syringes – An Insight.....II-104 $400  
   Factors Fuelling Demand.....II-10
Product Design And Trends.....II-10
1$100
   Advancements in Pre-Filled Syringes.....II-111$100
   Concerns –The Other Side.....II-12
2$200
  5. Issues Confronting the Industry.....II-141 $100  
   Disposal of Syringes - A Primary Issue.....II-14
1$100
  6. Product Innovations/Developments/Launches.....II-154 $400  
   MST Launches Turtle Safety Syringe .....II-15
Biocon Unveils ‘Nufil Safe’ and ‘Erypro Safe’ Pre-filled Syringes.....II-15
Indigo Orb Introduces Episure™ AutoDetect™ LOR Syringe.....II-15
Shire Introduces DYNEPO® Epoetin Delta with Delivery System.....II-15
Eisai Introduces Nitorol® Pre-filled Syringes.....II-15
1$100
   ConProTec Introduces Dual Barrel Syringes.....II-16
Nanoliter Unveils Non-Touch Syringe.....II-16
Amgen Introduces Aranesp® Prefilled SureClick™ Autoinjector.....II-16
Inviro Medical Introduces InviroSNAP! Safety Syringe.....II-16
1$100
   Unilife Launches New Insulin Syringe.....II-17
Stoelting Launches Syringes Product Line.....II-17
Cell Bio-Systems Launches Luer-to-Luer Transfer.....II-17
BD Launches SoloMed Syringe in Brazil.....II-17
Safety Syringes Together with AstraZeneca Rolls Out UltraSafe Passive Delivery
  System.....II-17
1$100
   Unitract Launches Retractable Syringes.....II-18
Safety Syringes Unveils UltraSafe Passive Delivery System.....II-18
Hindustan Syringes & Medical Devices Rolls Out Disposable Syringes.....II-18
1$100
  7. Recent Industry Activity.....II-1912 $800  
   Smiths Medical Announces Approval of Closed Blood Collection System.....II-19
Pharmaceutical Major Extends Agreement with Unilife.....II-19
Covidien to Acquire POWRSyringe Assets of Pinyons.....II-19
Inviro to Offer InviroSNAP!® Syringes to Health Affiliated Services Network.....II-19
Baxa Corporation’s Enteral Syringes Accepted on Contract.....II-19
1$100
   EWI Eastwest Interaction to Start New Ventures in Uzbekistan.....II-20
Teva Pharmaceutical Obtains FDA Approval for Longer Storage of COPAXONE(R) Pre-Filled
  Syringe.....II-20
Unilife’s Safety Syringe Approved by TGA.....II-20
Inviro Inks Supply Contract from Premier Purchasing Partners.....II-20
Retractable Technologies Bags Third Contract from the US Government.....II-20
1$100
   Unilife Inks Agreement with MedPro.....II-21
IMD Inks Agreement with Frontier.....II-21
Retractable Technologies Bags Contract from Queensland Health.....II-21
Unilife Inks Agreement with Gerresheimer Subsidiary.....II-21
1$100
   Hindustan Syringes to Expand Production Capacity.....II-22
Terumo Acquires Salymed.....II-22
Inviro Receives Supply Contract from Greer.....II-22
Inviro Inks Agreement with MedAssets.....II-22
Baxa Inks Joint Marketing Agreement with VIASYS.....II-22
1$100
   Occupational & Medical Innovations Gets Approval for Two OMI Syringes.....II-23
Unilife Medical Gets Approval for Sale of Safety Syringes in Europe.....II-23
BD to Develop and Expand its Manufacturing Base in Drogheda.....II-23
Coeur Acquires Contrast Delivery Repair Services.....II-23
IMD Inks Marketing Agreement with SafePro.....II-23
Matsushita and JCR Co-Develop Electric Syringe.....II-23
1$100
   Dolomite Technology to Start Joint Venture in China.....II-24
Global Medical Acquires Avanca Medical.....II-24
Ritract Delivers Safety Syringes to B Braun.....II-24
Bunzl Gets Clearance from UK OFT for Acquisition of Southern Syringe and Universal
  Hospital.....II-24
Mayne Pharma Pockets Intra-Tech (UK).....II-24
Poly Medicure Acquires Safety Syringes.....II-24
1$100
   Terumo Bags Distribution Agreement from Occupational & Medical.....II-25
Lupin Inks Marketing Agreement with ItalFarmco.....II-25
FDA Approves Devon Medical’s SharpShield™.....II-25
CryoLife Receives FDA Approval for BioGlue Syringe.....II-25
RiTract Begins Safety Syringe Shipments to the US.....II-25
Boca Recalls Ultilet Insulin Syringe (US).....II-25
UltiMed Files Lawsuit Against BD.....II-25
1$100
   Terumo Buys Distribution Rights of Contrast Media Products in Japan (Japan).....II-26
Southern Syringe Acquires HMS.....II-26
Maxxon Joins Forces with Globe Med Tech.....II-26
Unilife Obtains LOI from Chinese Company.....II-26
Retractable Technologies Signs Licensing Agreement in China.....II-26
Medical-Instill Enters into Agreement with GlaxoSmithKline.....II-26
RiTract Partners with B Braun.....II-26
1$100
   Unilife Medical Signs MOU.....II-27
IMD Group Syringes Receives Canadian approval.....II-27
Sigma Global Corporation Takes Over Global Health Services.....II-27
Maxxon Files Paptent Application for ReVac Safety Syringe.....II-27
BD Launches Online Help to Optimize Waste Space Usage in Syringes.....II-27
Analytica Ltd Acquires Retractable Technologies Pty Ltd.....II-27
1$100
   GE Takes Over Amersham.....II-28
Hindustan Latex and BD Enter into Agreement.....II-28
OMI Enters into Agreement with Terumo Medical Corp.....II-28
Globe Medical Tech Bags Safety Syringes Order.....II-28
Medical Devices Receives Supply Deal for Disposable Syringes.....II-28
RiTract’s Retractable Syringes Receive Clearance from TGA.....II-28
1$100
   Ensi-Med Receives Supply Contract.....II-29
Ambaji Opens a Disposable Syringe Unit.....II-29
McKinley Receives CE Mark For beeLINE Disposable Infusion Products Syringes.....II-29
Hindustan Syringes Establishes HMD Healthcare.....II-29
BD India to Enter Chinese Market.....II-29
Vietnam Medical Plastic Co Inks an Agreement.....II-29
1$100
   Orthovita Receives Clearance for Imbibe Syringes.....II-30
Terumo Enters into a Sales Agreement with Kyowa Hakko.....II-30
Genesis Biomedical Acquires ENSI-MED .....II-30
1$100
  8. Focus on Select Global Players.....II-314 $400  
   Becton, Dickinson and Company (USA).....II-31
BMDI TUTA Limited (Australia).....II-31
C. R. Bard, Inc (USA).....II-31
1$100
   Ensi-Med International Pty Limited (Australia).....II-32
Kawamoto Corporation (Japan).....II-32
Medline Industries Inc. (USA).....II-32
Merit Medical Systems, Inc.....II-32
1$100
   Safety Syringes, Inc. (US).....II-33
Smiths Medical International Limited (UK).....II-33
Terumo Corporation (Japan).....II-33
1$100
   Terumo Medical Corporation (USA).....II-34
1$100
  9. Global Market Perspective.....II-35   
   Table 1: World Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-351$350
   Table 2: World Long-term Projections for Syringes (Disposable and Reusable) by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-361$350
   Table 3: World10-Year Perspective for Syringes (Disposable and Reusable) by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-371$350
   Table 4: World Recent Past, Current & Future Analysis for Anesthesia Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-381$350
   Table 5: World Long-term Projections for Anesthesia Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-391$350
   Table 6: World10-Year Perspective for Anesthesia Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-401$350
   Table 7: World Recent Past, Current & Future Analysis for Angiographic Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-411$350
   Table 8: World Long-term Projections for Angiographic Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-421$350
   Table 9: World10-Year Perspective for Angiographic Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-431$350
   Table 10: World Recent Past, Current & Future Analysis for Blood Gas Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-441$350
   Table 11: World Long-term Projections for Blood Gas Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-451$350
   Table 12: World10-Year Perspective for Blood Gas Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-461$350
   Table 13: World Recent Past, Current & Future Analysis for Catheter Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-471$350
   Table 14: World Long-term Projections for Catheter Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-481$350
   Table 15: World10-Year Perspective for Catheter Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-491$350
   Table 16: World Recent Past, Current & Future Analysis for Dental Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-501$350
   Table 17: World Long-term Projections for Dental Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-511$350
   Table 18: World10-Year Perspective for Dental Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-521$350
   Table 19: World Recent Past, Current & Future Analysis for Ear Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-531$350
   Table 20: World Long-term Projections for Ear Syringes by Geographic Region –USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-541$350
   Table 21: World10-Year Perspective for Ear Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-551$350
   Table 22: World Recent Past, Current & Future Analysis for Hypodermic Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-561$350
   Table 23: World Long-term Projections for Hypodermic Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-571$350
   Table 24: World10-Year Perspective for Hypodermic Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-581$350
   Table 25: World Recent Past, Current & Future Analysis for Insulin Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-591$350
   Table 26: World Long-term Projections for Insulin Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-601$350
   Table 27: World10-Year Perspective for Insulin Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-611$350
   Table 28: World Recent Past, Current & Future Analysis for Intraligamentary Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-621$350
   Table 29: World Long-term Projections for Intraligamentary Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-631$350
   Table 30: World10-Year Perspective for Intraligamentary Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Middle East and Latin American Markets for Years2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-641$350
   Table 31: World Recent Past, Current & Future Analysis for Irrigating Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart).....II-651$350
   Table 32: World Long-term Projections for Irrigating Syringes by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-661$350
   Table 33: World10-Year Perspective for Irrigating Syringes by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets for Years 1991, 1995, 2005 & 2010 (includes corresponding Graph/Chart).....II-671$350
III. MARKET74$1650
  1. The United States.....III-117 $1225  
   A. Market Analysis.....III-1
Safety Syringes Report Healthy Growth.....III-1
Prefilled Syringes – Another Growing Market.....III-1
Competitive Scenario.....III-1
1$75
   Table 34: US Insulin Syringes Market (2005): Percentage Breakdown by Sales for Becton Dickinson, Kendall, and Others (includes corresponding Graph/Chart).....III-2

Table 35: US Market for Blood Collection Syringes and Needles (2005): Percentage Breakdown by Sales for Becton Dickinson, Kendall, Terumo Medical, and Others (includes corresponding Graph/Chart).....III-2

Table 36: US Market for Hypodermic Syringes and Needles (2005): Percentage Breakdown by Sales for Becton Dickinson, Kendall, Terumo Medical, and Others (includes corresponding Graph/Chart).....III-2
1$200
   Table 37: US Import of Syringes (with or without Needles) (2006 & 2007): Percentage Share Breakdown of Revenues by Leading Countries (includes corresponding Graph/Chart).....III-3

Table 38: US Export of Syringes (with or without Needles) (2006 & 2007): Percentage Share Breakdown of Revenues by Leading Countries (includes corresponding Graph/Chart).....III-3
1$200
   Product Launches.....III-42$150
   Strategic Corporate Development.....III-65$375
   Key Players.....III-114$300
   B. Market Analytics.....III-15
Table 39: US Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-15
1$200
   Table 40: US Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-161$200
   Table 41: US10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-17
1$200
  2. Canada.....III-183 $450  
   Market Analysis.....III-18
Table 42: Canadian Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-18
1$200
   Table 43: Canadian Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-191$200
   Table 44: Canadian10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-20
1$200
  3. Japan.....III-215 $575  
   A. Market Analysis.....III-21
Product Launches.....III-21
Strategic Corporate Developments.....III-21
1$75
   Key Japanese Players.....III-22
Kawamoto Corporation.....III-22
Terumo Corporation.....III-22
1$75
   B. Market Analytics.....III-23
Table 45: Japanese Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-23
1$200
   Table 46: Japanese Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-241$200
   Table 47: Japanese10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-25
1$200
  4. Europe.....III-266 $875  
   Market Analysis.....III-26
Table 48: European Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Geographic Region – France, Germany, Italy, The UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-26
1$200
   Table 49: European Long-term Projections for Syringes (Disposable and Reusable) by Geographic Region – France, Germany, Italy, The UK, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-271$200
   Table 50: European Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-281$200
   Table 51: European Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-291$200
   Table 52: European10-Year Perspective for Syringes (Disposable and Reusable) by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, The UK, Spain, Russia & Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-301$200
   Table 53: European10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-31
1$200
  4a. France.....III-323 $475  
   Market Analysis.....III-32
Table 54: French Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-32
1$200
   Table 55: French Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-331$200
   Table 56: French10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-34
1$200
  4b. Germany.....III-354 $500  
   A. Market Analysis.....III-35
Strategic Corporate Developments.....III-35
1$75
   B. Market Analytics.....III-36
Table 57: German Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-36
1$200
   Table 58: German Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-371$200
   Table 59: German10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-38
1$200
  4c. Italy.....III-393 $475  
   Market Analysis.....III-39
Table 60: Italian Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-39
1$200
   Table 61: Italian Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-401$200
   Table 62: Italian10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-41
1$200
  4d. The United Kingdom.....III-424 $500  
   A. Market Analysis.....III-42
Strategic Corporate Development.....III-42
1$75
   Key Player.....III-43
B. Market Analytics.....III-43
Table 63: UK Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-43
1$200
   Table 64: UK Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-441$200
   Table 65: UK10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-45
1$200
  4e. Spain.....III-463 $475  
   Market Analysis.....III-46
Table 66: Spanish Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-46
1$200
   Table 67: Spanish Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-471$200
   Table 68: Spanish10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-48
1$200
  4f. Russia.....III-493 $475  
   Market Analysis.....III-49
Table 69: Russian Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-49
1$200
   Table 70: Russian Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-501$200
   Table 71: Russian10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-51
1$200
  4g. Rest of Europe.....III-524 $500  
   A. Market Analysis.....III-52
Strategic Corporate Developments.....III-52
1$75
   B. Market Analytics.....III-53
Table 72: Rest of Europe Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-53
1$200
   Table 73: Rest of Europe Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-541$200
   Table 74: Rest of Europe10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-55
1$200
  5. Asia-Pacific.....III-5611 $875  
   A. Market Analysis.....III-56
India.....III-56
Potential for Auto Disposable Syringes in India.....III-56
China: A Potential Safety Syringes Market in the Making.....III-56
Product Developments/Launches.....III-56
1$75
   Strategic Corporate Developments.....III-574$300
   Key Players in Asia Pacific.....III-61
Ensi-Med International Pty Limited (Australia).....III-61
1$75
   BMDI TUTA Limited (Australia).....III-62
Hindustan Syringes & Medical Devices Ltd. (India).....III-62
Medi-Hut Int'l (Mfg.) Co., Ltd. (Korea).....III-62
1$75
   Occupational & Medical Innovations Ltd (Australia).....III-63
Unilife Medical Solutions Limited (Australia).....III-63
1$75
   B. Market Analytics.....III-64
Table 75: Asia-Pacific Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-64
1$200
   Table 76: Asia-Pacific Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-651$200
   Table 77: Asia-Pacific10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-66
1$200
  6. Middle East.....III-674 $500  
   A. Market Analysis.....III-67
Strategic Corporate Development.....III-67
1$75
   B. Market Analytics.....III-68
Table 78: Middle East Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) .....III-68
1$200
   Table 79: Middle East Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-691$200
   Table 80: Middle East10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-70
1$200
  7. Latin America.....III-714 $675  
   A. Market Analysis.....III-71
Strategic Corporate Developments.....III-71
1$75
   B. Market Analytics.....III-72
Table 81: Latin American Recent Past, Current & Future Analysis for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-72
1$200
   Table 82: Latin American Long-term Projections for Syringes (Disposable and Reusable) by Product Segments – Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-731$200
   Table 83: Latin American10-Year Perspective for Syringes (Disposable and Reusable) by Product Segments – Percentage Breakdown of Dollar Sales for Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes, Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes Markets for2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-741$200
IV. COMPETITIVE LANDSCAPE 281$995
  
Total Companies Profiled: 149 (including Divisions/Subsidiaries - 169)

Region/Country                 Players


The United States                  76   
Canada                              2
Japan                              10
Europe                             37
     France                         2   
     Germany                       16
     The United Kingdom             9
     Italy                          2
     Rest of Europe                 8
Asia-Pacific (Excluding Japan)     40
Middle East                         4
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2009, Global Industry Analysts, Inc., USA.